These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7740453)

  • 21. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deencryption of cellular tissue factor is independent of its cytoplasmic domain.
    Wolberg AS; Kon RH; Monroe DM; Ezban M; Roberts HR; Hoffman M
    Biochem Biophys Res Commun; 2000 Jun; 272(2):332-6. PubMed ID: 10833414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of tissue factor activation on cells.
    Bach RR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S37-43. PubMed ID: 9819027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for activation of tissue factor by an allosteric disulfide bond.
    Chen VM; Ahamed J; Versteeg HH; Berndt MC; Ruf W; Hogg PJ
    Biochemistry; 2006 Oct; 45(39):12020-8. PubMed ID: 17002301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3.
    Fang CH; Lin TC; Guha A; Nemerson Y; Konigsberg WH
    Thromb Haemost; 1996 Sep; 76(3):361-8. PubMed ID: 8883271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity.
    Rao LV; Tait JF; Hoang AD
    Thromb Res; 1992 Sep; 67(5):517-31. PubMed ID: 1448786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant expression of tissue factor and its activity in polarized epithelial cells. Asymmetry in anionic phospholipid availability as a possible explanation.
    Hansen CB; van Deurs B; Petersen LC; Rao LV
    Blood; 1999 Sep; 94(5):1657-64. PubMed ID: 10477690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Annexin A5 inhibits homocysteine-induced tissue factor expression and activity in vascular smooth muscle cells].
    Li J; Chen T; Wang DM; Song YF; Hong M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):1039-43. PubMed ID: 20137335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.
    Ruf W; Rehemtulla A; Morrissey JH; Edgington TS
    J Biol Chem; 1991 Feb; 266(4):2158-66. PubMed ID: 1989976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model.
    Almus FE; Rao LV; Rapaport SI
    Arterioscler Thromb; 1993 Jan; 13(1):105-11. PubMed ID: 8422331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa.
    Kelly CR; Schullek JR; Ruf W; Edgington TS
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):145-51. PubMed ID: 8670099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.
    Friederich PW; Levi M; Bauer KA; Vlasuk GP; Rote WE; Breederveld D; Keller T; Spataro M; Barzegar S; Büller HR
    Circulation; 2001 May; 103(21):2555-9. PubMed ID: 11382723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor.
    Hansen CB; Pyke C; Petersen LC; Rao LV
    Blood; 2001 Mar; 97(6):1712-20. PubMed ID: 11238112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue factor: regulation of activity by flow and phospholipid surfaces.
    Andree HA; Nemerson Y
    Blood Coagul Fibrinolysis; 1995 May; 6(3):189-97. PubMed ID: 7654932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an oriented transmembrane protein to probe the assembly of a supported phospholipid bilayer.
    Contino PB; Hasselbacher CA; Ross JB; Nemerson Y
    Biophys J; 1994 Sep; 67(3):1113-6. PubMed ID: 7811922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor.
    Sakai T; Lund-Hansen T; Thim L; Kisiel W
    J Biol Chem; 1990 Feb; 265(4):1890-4. PubMed ID: 2298729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated function of blood clotting factor VIIa mutants that have enhanced affinity for membranes. Behavior in a diffusion-limited reaction.
    Nelsestuen GL; Stone M; Martinez MB; Harvey SB; Foster D; Kisiel W
    J Biol Chem; 2001 Oct; 276(43):39825-31. PubMed ID: 11517221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the activation of factor VII bound to tissue factor.
    Rao LV; Williams T; Rapaport SI
    Blood; 1996 May; 87(9):3738-48. PubMed ID: 8611699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
    Hoffman M; Monroe DM; Roberts HR
    Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.